Inna Etinberg
Partner
Inna Etinberg joined OEP in 2013 and is a Partner based in New York. Ms. Etinberg has focused on investments in healthcare, industrials and business services. Ms. Etinberg is a director on the Board of Directors of RestorixHealth, Infucare Rx, Montgomery Transport, Norit Activated Carbon, and React Health, and a Board observer at AdaptHealth. Ms. Etinberg was previously a director on the Board of Directors at PS Logistics, The Results Companies, OneLink, Simplura Health Group and was involved in OEP’s realized investments in PeroxyChem, Sonneborn, East Balt and EGS.
Prior to joining OEP, Ms. Etinberg worked in the Investment Banking division of JPMorgan in the Diversified Industries Group where she focused on the industrials, aerospace & defense and automotive sectors. Ms. Etinberg received her B.A. in Economics from Dartmouth College.
News
05.05.22
One Equity Partners Completes Investment in React Health, a Leading Sleep Therapy, Respiratory Therapy and Disinfection Products Manufacturer and Distributor
02.25.22
One Equity Partners Invests in Montgomery Transport
01.12.22
One Equity Partners Completes Investment in InfuCare Rx, a Leading Home Infusion Therapy Provider
10.13.21
One Equity Partners Exits Investment in PS Logistics
10.04.21
One Equity Partners Completes Sale of ResultsCX
07.13.21
One Equity Partners Agrees to Sell OneLink Holdings
08.01.17